On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol.

<h4>Introduction</h4>Induced pluripotent stem cells (iPSCs) are cells derived from somatic cells via reprogramming techniques. The iPSC approach has been increasingly used in neuropsychiatric research in the last decade. Though substance use disorders (SUDs) are a commonly occurring psyc...

Full description

Saved in:
Bibliographic Details
Main Authors: Wasiri Niemis, Shenita R Peterson, Chrisabella Javier, Amy Nguyen, Sanchi Subiah, Rohan H C Palmer
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292238&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540130862170112
author Wasiri Niemis
Shenita R Peterson
Chrisabella Javier
Amy Nguyen
Sanchi Subiah
Rohan H C Palmer
author_facet Wasiri Niemis
Shenita R Peterson
Chrisabella Javier
Amy Nguyen
Sanchi Subiah
Rohan H C Palmer
author_sort Wasiri Niemis
collection DOAJ
description <h4>Introduction</h4>Induced pluripotent stem cells (iPSCs) are cells derived from somatic cells via reprogramming techniques. The iPSC approach has been increasingly used in neuropsychiatric research in the last decade. Though substance use disorders (SUDs) are a commonly occurring psychiatric disorder, the application of iPSC model in addiction research has been limited. No comprehensive review has been reported. We conducted a scoping review to collate existing evidence on the iPSC technologies applied to SUD research. We aim to identify current knowledge gaps and limitations in order to advance the use of iPSCs in the SUD field.<h4>Methods and analysis</h4>We employed a scoping review using the methodological framework first created by Arksey and O'Malley and further updated by Levac et al. and the Joanna Briggs Institute (JBI). We adopted the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Protocols (PRISMA-P) to report items for the protocol. We searched evidence from four electronic databases: PubMed®, Embase®, Web of Science™, and Scopus®. Primary research, systematic reviews, and meta-analyses were included and limited to studies published in English, at the time from 2007 to March 2022. This is an "ongoing" scoping review. Searched studies will be independently screened, selected, and extracted by two reviewers. Disagreement will be solved by the third reviewer and discussion. Extracted data will be analyzed in descriptive and quantitative approaches, then summarized and presented in appropriate formats. Results will be reported following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guideline and disseminated through a peer-reviewed publication and conference presentations.<h4>Conclusion</h4>To our best knowledge, this is the first comprehensive scoping review of iPSC methods specifically applied to a broad range of addictive drugs/substances that lead to SUDs or misuse behavior.<h4>Registration</h4>This protocol is registered on Zenodo repository (https://zenodo.org/) with doi:10.5281/zenodo.7915252.
format Article
id doaj-art-a04e86116203498a9573016b598691c4
institution Kabale University
issn 1932-6203
language English
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-a04e86116203498a9573016b598691c42025-02-05T05:32:36ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-011810e029223810.1371/journal.pone.0292238On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol.Wasiri NiemisShenita R PetersonChrisabella JavierAmy NguyenSanchi SubiahRohan H C Palmer<h4>Introduction</h4>Induced pluripotent stem cells (iPSCs) are cells derived from somatic cells via reprogramming techniques. The iPSC approach has been increasingly used in neuropsychiatric research in the last decade. Though substance use disorders (SUDs) are a commonly occurring psychiatric disorder, the application of iPSC model in addiction research has been limited. No comprehensive review has been reported. We conducted a scoping review to collate existing evidence on the iPSC technologies applied to SUD research. We aim to identify current knowledge gaps and limitations in order to advance the use of iPSCs in the SUD field.<h4>Methods and analysis</h4>We employed a scoping review using the methodological framework first created by Arksey and O'Malley and further updated by Levac et al. and the Joanna Briggs Institute (JBI). We adopted the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Protocols (PRISMA-P) to report items for the protocol. We searched evidence from four electronic databases: PubMed®, Embase®, Web of Science™, and Scopus®. Primary research, systematic reviews, and meta-analyses were included and limited to studies published in English, at the time from 2007 to March 2022. This is an "ongoing" scoping review. Searched studies will be independently screened, selected, and extracted by two reviewers. Disagreement will be solved by the third reviewer and discussion. Extracted data will be analyzed in descriptive and quantitative approaches, then summarized and presented in appropriate formats. Results will be reported following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guideline and disseminated through a peer-reviewed publication and conference presentations.<h4>Conclusion</h4>To our best knowledge, this is the first comprehensive scoping review of iPSC methods specifically applied to a broad range of addictive drugs/substances that lead to SUDs or misuse behavior.<h4>Registration</h4>This protocol is registered on Zenodo repository (https://zenodo.org/) with doi:10.5281/zenodo.7915252.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292238&type=printable
spellingShingle Wasiri Niemis
Shenita R Peterson
Chrisabella Javier
Amy Nguyen
Sanchi Subiah
Rohan H C Palmer
On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol.
PLoS ONE
title On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol.
title_full On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol.
title_fullStr On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol.
title_full_unstemmed On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol.
title_short On the utilization of the induced pluripotent stem cell (iPSC) model to study substance use disorders: A scoping review protocol.
title_sort on the utilization of the induced pluripotent stem cell ipsc model to study substance use disorders a scoping review protocol
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292238&type=printable
work_keys_str_mv AT wasiriniemis ontheutilizationoftheinducedpluripotentstemcellipscmodeltostudysubstanceusedisordersascopingreviewprotocol
AT shenitarpeterson ontheutilizationoftheinducedpluripotentstemcellipscmodeltostudysubstanceusedisordersascopingreviewprotocol
AT chrisabellajavier ontheutilizationoftheinducedpluripotentstemcellipscmodeltostudysubstanceusedisordersascopingreviewprotocol
AT amynguyen ontheutilizationoftheinducedpluripotentstemcellipscmodeltostudysubstanceusedisordersascopingreviewprotocol
AT sanchisubiah ontheutilizationoftheinducedpluripotentstemcellipscmodeltostudysubstanceusedisordersascopingreviewprotocol
AT rohanhcpalmer ontheutilizationoftheinducedpluripotentstemcellipscmodeltostudysubstanceusedisordersascopingreviewprotocol